ロード中...
A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
There have been extensive efforts to improve the outcome of glioblastoma, but the prognosis of this disease has not been significantly altered to date. Histone deacetylase inhibitors (HDACIs) have been evaluated as promising anti-cancer drugs and regulate cell growth, cell cycle arrest and apoptosis...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5354719/ https://ncbi.nlm.nih.gov/pubmed/27852054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13265 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|